No headlines found.
No press releases found.
No news found.
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Invesco Nasdaq Biotechnology ETF trades on the NASDAQ stock market under the symbol IBBQ.
As of January 14, 2026, IBBQ stock price climbed to $28.90 with 24,958 million shares trading.
IBBQ has a beta of 0.74, meaning it tends to be less sensitive to market movements. IBBQ has a correlation of 0.36 to the broad based SPY ETF.
IBBQ has a market cap of $68.49 million. This is considered a Micro Cap stock.
In the last 3 years, IBBQ traded as high as $29.92 and as low as $17.84.
IBBQ has outperformed the market in the last year with a price return of +34.9% while the SPY ETF gained +19.6%. IBBQ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.5% and +1.8%, respectively, while the SPY returned +4.1% and +0.2%, respectively.
IBBQ support price is $28.37 and resistance is $29.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBBQ shares will trade within this expected range on the day.
